iShares U.S. Pharmaceuticals ETF (IHE) Holdings $69.31 +0.01 (+0.01%) (As of 12:44 PM ET) Add Compare Share Share Holdings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings Top 42 IHE HoldingsRankCompanyCurrent PriceWeightShares Held1JNJJohnson & Johnson$153.48-0.9%22.06%851,4812LLYEli Lilly and Company$813.74+1.7%18.83%152,3983BMYBristol-Myers Squibb$59.35-1.0%5.70%577,6534VTRSViatris$13.15-0.4%5.47%2,475,1625CTLTCatalent$61.92+0.8%4.41%442,1276ZTSZoetis$180.03+1.8%4.39%147,733 Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 7RPRXRoyalty Pharma$26.29-0.5%4.17%947,4908PFEPfizer$25.68-0.5%4.02%946,3329MRKMerck & Co., Inc.$102.19+1.6%4.00%244,69410ITCIIntra-Cellular Therapies$85.42-0.7%3.39%240,07511JAZZJazz Pharmaceuticals$121.92+0.3%2.98%150,86612ELANElanco Animal Health$12.80-5.0%2.72%1,207,61713CORTCorcept Therapeutics$58.32-1.5%2.09%227,18614PBHPrestige Consumer Healthcare$84.23-0.9%1.69%121,06615AXSMAxsome Therapeutics$100.46+1.4%1.59%98,50116OGNOrganon & Co.$15.61+0.3%1.55%628,99517PRGOPerrigo$28.45-0.1%1.54%333,25618LGNDLigand Pharmaceuticals$120.78-1.6%0.84%44,63219SUPNSupernus Pharmaceuticals$36.65-1.8%0.81%134,61620EWTXEdgewise Therapeutics$31.88+1.1%0.76%142,03521AMPHAmphastar Pharmaceuticals$44.83-2.3%0.69%92,75322TARSTarsus Pharmaceuticals$49.80-1.2%0.67%84,56923ARVNArvinas$25.20-2.0%0.57%155,96724AMRXAmneal Pharmaceuticals$8.52-0.6%0.52%361,93025SAVACassava Sciences$3.50+1.4%0.52%110,17626HRMYHarmony Biosciences$35.120.0%0.51%92,92027INVAInnoviva$19.00-0.6%0.43%134,49528COLLCollegium Pharmaceutical$31.33+2.7%0.40%78,69429ANIPANI Pharmaceuticals$56.96-1.6%0.38%40,52930NMRANeumora Therapeutics$9.64-1.6%0.34%203,28631ELVNEnliven Therapeutics$23.17-5.2%0.32%71,54932PCRXPacira BioSciences$16.93-4.9%0.32%112,68333PLRXPliant Therapeutics$14.90-3.9%0.28%130,71534MNMDMind Medicine (MindMed)$7.63-6.3%0.22%178,69935NUVBNuvation Bio$2.97-0.3%0.18%412,14536USD CASHN/A0.15%869,91537PHATPhathom Pharmaceuticals$8.74+0.3%0.14%87,35038RVNCRevance Therapeutics$3.82+2.4%0.14%218,79539TBPHTheravance Biopharma$9.68+2.5%0.14%85,27440BlackRock Cash Funds Treasury SL AgencyN/A0.05%310,570[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin41CASH COLLATERAL USD SGAFTN/A0.01%64,00042E-MINI HEALTH CARE SECTOR DEC 24N/A0.00%8 Geographic ExposureUnited States94.9%Ireland4.6%Cayman Islands0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care89.9%Energy0.4%Industry ExposureBiotechnology73.0%Pharmaceuticals7.2%Health Care Equipment & Supplies4.4%Renewable Energy0.4%SubIndustry ExposureBiotechnology70.2%Pharmaceuticals8.8%Health Care Equipment4.4%Renewable Energy Equipment0.4%Coupon Exposure0-299.9%4-60.1% Related Companies and Tools Related Companies VanEck Pharmaceutical ETF Portfolio iShares U.S. Healthcare Providers ETF Portfolio VanEck Biotech ETF Portfolio Direxion Daily S&P Biotech Bull 3x Shares Portfolio Invesco S&P 500 Equal Weight Health Care ETF Portfolio Invesco Pharmaceuticals ETF Portfolio Invesco Biotechnology & Genome ETF Portfolio SPDR S&P Health Care Equipment ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio Direxion Daily Healthcare Bull 3x Shares Portfolio This page (NYSEARCA:IHE) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
